Heang M. Lim

Heang M. Lim

Pediatric Cardiology | Pediatrics

1540 E Hospital Dr
Floor 11 Reception C
Ann Arbor, MI 48109

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

The congenital heart early-career exchange programme: collaboration to advance faculty development - CORRIGENDUM.

The congenital heart early-career exchange programme: collaboration to advance faculty development - CORRIGENDUM.

Journal: Cardiology in the young

Published: August 10, 2026

The congenital heart early-career exchange programme: collaboration to advance faculty development.

The congenital heart early-career exchange programme: collaboration to advance faculty development.

Journal: Cardiology in the young

Published: June 18, 2026

Characteristics Associated with Poor Long-Term Outcomes in Patients with Fontan Palliation: A Case-Control Study.

Characteristics Associated with Poor Long-Term Outcomes in Patients with Fontan Palliation: A Case-Control Study.

Journal: Pediatric cardiology

Published: March 15, 2026

Early donor-specific antibodies in pediatric patients with Fontan circulation after heart transplant.

Early donor-specific antibodies in pediatric patients with Fontan circulation after heart transplant.

Journal: Transplant immunology

Published: October 16, 2025

Early donor-specific antibodies in pediatric patients with Fontan circulation after heart transplant.

Early donor-specific antibodies in pediatric patients with Fontan circulation after heart transplant.

Journal: Transplant immunology

Published: October 16, 2025

Cardiovascular Care in Pediatric Cancer Survivors: Updates on Risk, Prevention, and Therapies.

Cardiovascular Care in Pediatric Cancer Survivors: Updates on Risk, Prevention, and Therapies.

Journal: Current treatment options in oncology

Published: September 26, 2025

Correction: Single-Center Experience with Sacubitril/Valsartan in Patients with Congenital Heart Disease.

Correction: Single-Center Experience with Sacubitril/Valsartan in Patients with Congenital Heart Disease.

Journal: Pediatric cardiology

Published: July 28, 2025

Donor-Derived Cell-Free DNA as a Marker for the Efficacy of Daratumumab in Patients With Antibody-Mediated Rejection Post-Heart Transplantation: A Case Series.

Donor-Derived Cell-Free DNA as a Marker for the Efficacy of Daratumumab in Patients With Antibody-Mediated Rejection Post-Heart Transplantation: A Case Series.

Journal: Pediatric transplantation

Published: May 12, 2025

Prostacyclin Therapy as Adjunctive Treatment for Pulmonary Hypertension in Pediatric Heart Transplantation: A Case Report.

Prostacyclin Therapy as Adjunctive Treatment for Pulmonary Hypertension in Pediatric Heart Transplantation: A Case Report.

Journal: Pediatric transplantation

Published: April 28, 2025

Single-Center Experience with Sacubitril/Valsartan in Patients with Congenital Heart Disease.

Single-Center Experience with Sacubitril/Valsartan in Patients with Congenital Heart Disease.

Journal: Pediatric cardiology

Published: April 03, 2025

Identifying Frailty and Its Risk Factors in Pediatric Patients with Fontan Physiology.

Identifying Frailty and Its Risk Factors in Pediatric Patients with Fontan Physiology.

Journal: Pediatric cardiology

Published: August 09, 2024

Discordance Between Caregiver and Transplant Clinician Priorities Regarding Post-Heart Transplant Education.

Discordance Between Caregiver and Transplant Clinician Priorities Regarding Post-Heart Transplant Education.

Journal: Pediatric transplantation

Published: June 18, 2024

Showing 1-12 of 28

Last Updated: 09/26/2026